Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04271917Phase 3Completed
Phase 3, randomised, double-blind trial of cannabidiol in acute pain (4 arms), sponsored by University of Tennessee. Primary endpoints: Worst pain following surgery at 1 week, Amount of medication used at 1 week and 1 more. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04271917.